ADC	Antibody–drug Conjugate
ASCT	autologous stem cell transplantation
BM	bone marrow
Bz	bortezomib
CAR-T	chimeric antigen receptor T
CELMoDs	cereblon E3 ligase modulators
Dara	Daratumumab
DEX	dexamethasone
DOR	duration of response
MDR1/ABCB1	multidrug resistance protein 1
MM	Multiple Myeloma
NR	Not reached
ORR	overall response rate
OS	Overall Survival
PFS	progression-free survival
PI	Proteasome inhibitor
Pom	Pomalidomide
RRMM	relapsed or refractory multiple myeloma
SINE	selective inhibitors of nuclear export
TCE	T-cell engagers